Oxaceprol
![]() | |
| Gene therapy | |
|---|---|
| Clinical data | |
| Other names | (2S,4R)-1-acetyl-4-hydroxypyrrolidine-2-carboxylic acid |
| AHFS/Drugs.com | International Drug Names |
| ATC code | |
| Physiological data | |
| Legal status | |
| Pharmacokinetic data | |
| Identifiers | |
| |
| CAS Number | |
| PubChem Template:Abbreviation | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C7H11NO4 |
| Molar mass | 172.159 g/mol |
| 3D model (JSmol) | |
| |
| |
| (verify) | |
|
WikiDoc Resources for Oxaceprol |
|
Articles |
|---|
|
Most recent articles on Oxaceprol |
|
Media |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Oxaceprol at Clinical Trials.gov Clinical Trials on Oxaceprol at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Oxaceprol
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Oxaceprol Discussion groups on Oxaceprol Directions to Hospitals Treating Oxaceprol Risk calculators and risk factors for Oxaceprol
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Oxaceprol |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Oxaceprol is an anti-inflammatory drug used in the treatment of osteoarthritis.[1] It is derived from L-proline, a DNA-encoded amino acid. The active effect of Oxaceprol is to inhibit the adhesion and migration of white blood cells.
References
- Pages with citations using unsupported parameters
- Articles with short description
- Template:drugs.com link with non-standard subpage
- Infobox-drug molecular-weight unexpected-character
- Pages using infobox drug with unknown parameters
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Pyrrolidines
- Alcohols
- Drug
